Dashboard
Manage Tickers

INGN Inogen Inc

Nasdaq inogen.com


$ 8.37 $ -0.14 (-1.65 %)    

Friday, 17-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 8.37
$ 8.45
$ 8.00 x 20
$ 8.85 x 7
$ 8.36 - $ 8.55
$ 5.70 - $ 12.91
158,790
na
226.33M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-01-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 04-30-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-14-2016 12-31-2015 10-K
40 11-10-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inogen-raises-fy2025-sales-guidance-from-352000m-355000m-to-354000m-357000m-vs-353700m-est
Inogen Raises FY2025 Sales Guidance from $...
08/07/2025 20:30:00

Inogen (NASDAQ:INGN) raises FY2025 sales outlook from $352.000 million-$355.000 million to $354.000 million-$357.000 million vs...

inogen-sees-q3-sales-91000m-93000m-vs-93267m-est
Inogen Sees Q3 Sales $91.000M-$93.000M vs ...
08/07/2025 20:29:48

Inogen (NASDAQ:INGN) sees Q3 sales of $91.000 million-$93.000 million vs $93.267 million analyst estimate.

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

b-riley-securities-initiates-coverage-on-inogen-with-buy-rating-announces-price-target-of-14
B. Riley Securities Initiates Coverage On ...
06/16/2025 17:31:55

B. Riley Securities analyst Anderson Schock initiates coverage on Inogen (NASDAQ:INGN) with a Buy rating and announces Price...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/10/2025 21:05:50

inogen-upgraded-analyst-sees-growth-ebitda-breakthrough
Inogen Upgraded: Analyst Sees Growth, EBIT...
05/22/2025 17:38:53

Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.

this-united-rentals-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This United Rentals Analyst Turns Bullish;...
05/22/2025 12:17:23

needham-upgrades-inogen-to-buy-announces-12-price-target
Needham Upgrades Inogen to Buy, Announces ...
05/22/2025 10:25:24

Needham analyst Mike Matson upgrades Inogen (NASDAQ:INGN) from Hold to Buy and announces $12 price target.

stifel-maintains-hold-on-inogen-lowers-price-target-to-7
Stifel Maintains Hold on Inogen, Lowers Pr...
05/08/2025 13:56:01

Stifel analyst Mathew Blackman maintains Inogen (NASDAQ:INGN) with a Hold and lowers the price target from $10 to $7.

inogen-sees-q2-sales-89000m-91000m-vs-9273m-est
Inogen Sees Q2 Sales $89.000M-$91.000M vs ...
05/07/2025 20:21:20

Inogen (NASDAQ:INGN) sees Q2 sales of $89.000 million-$91.000 million vs $92.73 million analyst estimate.

inogen-affirms-fy2025-sales-guidance-of-35200m-35500m-vs-35281m-est
Inogen Affirms FY2025 Sales Guidance of $3...
05/07/2025 20:21:05

Inogen (NASDAQ:INGN) affirms FY2025 sales outlook from $352.00 million-$355.00 million to $352.00 million-$355.00 million vs $3...

inogen-q1-adj-eps-011-beats-050-estimate-sales-8228m-beat-7955m-estimate
Inogen Q1 Adj. EPS $(0.11) Beats $(0.50) E...
05/07/2025 20:20:46

Inogen (NASDAQ:INGN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.50) by 78 ...

Core News & Articles
Earnings Scheduled For May 7, 2025
05/07/2025 08:33:08

needham-reiterates-hold-on-inogento-hold
Needham Reiterates Hold on Inogento Hold
04/09/2025 12:38:15

Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) from Hold to Hold.

needham-reiterates-hold-on-inogento-hold
Needham Reiterates Hold on Inogento Hold
02/27/2025 11:19:14

Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) from Hold to Hold.

whats-going-on-with-medtech-focused-inogen-stock-on-wednesday
What's Going On With MedTech Focused Inoge...
02/26/2025 21:21:16

Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and ...

needham-reiterates-hold-on-inogento-hold
Needham Reiterates Hold on Inogento Hold
02/26/2025 11:21:13

Needham analyst Mike Matson reiterates Inogen (NASDAQ:INGN) from Hold to Hold.

inogen-sees-fy2025-sales-352000m-355000m-vs-34461m-est
Inogen Sees FY2025 Sales $352.000M-$355.00...
02/25/2025 21:45:50

Inogen (NASDAQ:INGN) sees FY2025 sales of $352.000 million-$355.000 million vs $344.61 million analyst estimate.

inogen-sees-q1-sales-79000m-81000m-vs-7808m-est
Inogen Sees Q1 Sales $79.000M-$81.000M vs ...
02/25/2025 21:45:38

Inogen (NASDAQ:INGN) sees Q1 sales of $79.000 million-$81.000 million vs $78.08 million analyst estimate.

inogen-q4-adj-024-beats-061-estimate-sales-8008m-beat-7391m-estimate
Inogen Q4 Adj $(0.24) Beats $(0.61) Estima...
02/25/2025 21:41:32

Inogen (NASDAQ:INGN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.61) by 60....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION